Clinical trial
Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable…
NCT00444041 · Austrian Society Of Surgical Oncology, Other · Completed
Key facts
| NCT number | NCT00444041 |
|---|---|
| Title | Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer |
| Official title | Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer (mCRC). A Multicenter, Single Arm Phase I/II Academic Trial |
| Acronym | ASSO-LM1 |
| Lead sponsor | Austrian Society Of Surgical Oncology, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Bevacizumab |
| Enrollment | 43 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Mar 7, 2007 |
| Last update posted | Jan 30, 2013 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: